New algorithm aims to prevent organ rejection in young kidney patients
NCT ID NCT07549230
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will develop a computer tool to help doctors give the right dose of tacrolimus to children who have received a kidney transplant. The goal is to keep tacrolimus levels in a safe and effective range, reducing the risk of the body rejecting the new kidney. Researchers will use data from 130 children to build and test the dosing algorithm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tacrolimus
- What this could lead to
- If successful, this could provide a more accurate way to dose tacrolimus in children after kidney transplant, potentially lowering the chance of organ rejection.
- What could go wrong
- This is an early-stage study that has not yet started recruiting. The algorithm may not perform better than current methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.